size demand timstof
rais pt equal weight
one top new product launch life scienc tool coverag
get question timstof mass spectrometri
dilig asm industri expert believ real
demand platform field proteom view launch
import contributor bruker project acceler
initi
compani effort achiev organ growth target laid june
analyst day follow review rais organ growth adj ep
forecast well pt said maintain
equal weight rate think current peer-averag multipl fair valu
given compani growth profil capit equip exposur
thursday host industri expert lunch focus trend mass
spectrometri focu proteom overal expert believ room
proteom market growth technolog improv drive opportun
translat proteom research clinic expert bullish
prospect timstof offer new solut proteom research
platform earli data view crazi good expect broader adopt
system key opinion leader experi platform thermo fisher
orbitrap still view foundat platform research lab expect
timstof compet wallet share new purchas thermo fisher
continu innov platform context estim orbitrap
repres total sale
note made improv model believ
find valuabl notabl embed formal estim timstof
maldi-tof busi within calid well ultra-high field nmr placement
within biospin pleas reach copi model welcom feedback
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
equal weight view thesi
balanc biggest turnaround
stori life scienc tool coverag
begin see earli sign better sale
manag system drive higher earn
compani said revenu visibl
weaken remain cautiou around
execut success
expect aid new manag system
support fund environ appli
ebitda multipl upsid ebitda
million yield upsid case
execut issu fund capit purchas
drive downsid ebitda forecast
case
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
one top new product launch life scienc tool coverag
get question timstof mass spectrometri
dilig asm industri expert believ real demand
platform field proteom view launch import contributor
bruker project acceler initi compani effort achiev
organ growth target laid june analyst day follow review
rais forecast well pt said
maintain equal weight rate think current peer-avg multipl fair valu
given compani growth profil capit equip exposur
describ detail believ bruker timstof system continu build
traction market high resolut proteom research follow launch
septemb technolog base trap ion mobil tim provid
ultra high resolut sampl coupl ms-m detector platform
resolut full speed greater competit method better
quantit low level mass detect place dozen system
field expect continu build next sever year system
primarili adopt academ govern custom well
biopharma discoveri price point timstof around expect
near-term aftermarket sale predominantli servic limit consum gener
size proteom mass spec market today today market
domin thermo fisher orbitrap platform estim
roughli market share said see opportun drive market expans
year given market demand larg cohort studi greater adopt
biopharma organ well demand singl cell clinic proteom
updat model estim placement continu acceler
next sever year timstof product line
timstof current limit releas earli stage new product
cycl anticip enough capac meet near-term demand
manag think platform earn market share near futur
context estim thermo fisher place orbitrap instrument per year
timstof platform duct launch contribut growth
pleas see
thought outlin
strategi acceler growth
perspect timstof one sever initi focus
part project acceler program recommend focus three
launch view biggest near-term needle-mov timstof
platform proteom ultra-high field nmr system microbiolog diagnost
addit drive better top-lin growth expect new product import
contributor abil drive margin expans per year
follow review rais organ growth adj ep forecast
notabl see organ growth steadili improv
midpoint target growth also rais adj
ep forecast low-to-mid teen per year bullish timstof
forecast also think bruker long-term guid consensu forecast model
success launch ep forecast street also note
forecast toward upper end long-term guid
barclay vs consensu forecast
 phenomicstimstof teomic ghz nmrmass spec base phenom ghz nmrbiopharma appliedadvanc nmr mass spec solut drug discoveri develop qa/qcftir nir raman nmr mass spec appli marketsmicrobiolog dxmaldi biotyp consum ramp bruker mdx assaysblood cultur id suscept test liquid arraysneurosci cell multiphoton lattic tight sheet microscopi spim rampfurth next-gen microscopi productsnext-gen nanotech semi toolsuniqu x-ray metrolog autom afm toolsxcd rampafter-marketservic consumablesscientif softwar adj adj researchconsensusbarc vs streetbarclay research barclay bruker corp
overal impress progress think compani right
path bruker organ growth target repres acceler recent trend
despit moder macro environ result believ bruker abil leverag
growth driver achiev also valuat sensit follow big run
compani stock year believ reflect optim around higher
growth stock increas ytd vs life scienc
tool averag compani trade ntm
ebitda discount life scienc tool peer gap close recent
month compar averag discount reiter equal weight
rate though higher confid potenti timstof rais
pt price target repres adj ebitda
prior pt repres ebitda estim
organ revenu growth ep growth
rel ev/ntm ebitda valuat vs tool peer
 ebitdabrkr otool relativerel revepsadj epsorgan revenueaftermarket revenu barclay bruker corp
tim parallel accumul serial fragment pasef technolog drive
higher speed capabl shotgun proteom method identifi
protein complex mixtur mass spectromet often util proteom
obtain mass spectra matter second scan whole mass rang fragment
mani peptid possibl timstof built quadrupol mass spec
util nanoelut hplc peak studio softwar proprietari tim technolog
enabl evalu peptid ion enter mass spectromet peptid ion
accumul first part devic trap ion mobil separ occur
time subsequ region result timstof high spectral qualiti
pasef technolog enabl timstof achiev nearli duti cycl
relat percentag ion interest analyz ion
beam tradit quadrupol ms instrument featur lower duti cycl
contribut lower sensit level appli pasef hundr ms-m event
per second high sensit full resolv power gener synchron
quadrupol mass isol posit period time trap ion mobil
separ ion piec elut tim devic typic millisecond
histor main drawback util ms proteom sequenc speed
result fraction peptid separ howev combin
tim pasef technolog increas speed sequenc hz without
lose sensit resolut speed greater competit method
particularli advantag situat limit sampl avail
biopsi contrast thermo fisher latest orbitrap upgrad asm
explori eclips tribrid featur sequenc speed hz hz respect
mass spec proteom platform comparison
expert view lunch demand
thursday host industri expert lunch focus trend mass
spectrometri focu proteom overal expert believ room
proteom market growth technolog improv drive opportun translat
proteom research clinic expert bullish prospect
timstof offer new solut proteom research platform earli
data view crazi good expect broader adopt system key
opinion leader experi platform thermo fisher orbitrap still
view foundat platform research lab expect timstof
compet wallet share new purchas thermo fisher continu innov
platform context estim orbitrap repres total sale
research saw broaden demand mass spectrometri time
proteom industri translat research studi clinic diagnost expert
compar current stage proteom research genom industri decad
platformsequenc speedresolutionscan rangecycl timeflow ratequanititative/qualit analysiss mm mainten requiredtimstof m/ nl/minquanitit explori l/min eclips tribrid hzup l/min barclay bruker corp
ago higher-throughput platform help pave way increas demand
advanc research histor field proteom held back
throughput instrument lack consist amongst technician platform
high level downtime/repair need dr wilson describ industri
linear phase s-curv model expect break next sever
quarter sensit data acquisit specif improv manufactur
introduc new product futur opportun remain make platform
integr system workflow
expert agre thermo fisher incred influenti proteom
orbitrap platform first mass spec analyz type proteom
thermo fisher introduc number orbitrap model year includ
exact lumo thermo fisher describ good instrument
softwar offer given thermo fisher scale field proteom believ
manufactur capac salesforc servic breadth also advantag
compani said recent upgrad view increment
improv softwar drive greater resolut throughput
contrast expert view timstof transform launch given
base new technolog dr wilson discuss purport benefit timstof
speed uptim duti cycl also believ could advantag uptim
timstof oper could find valu platform effici dr wilson
also note timstof offer advanc resolut accuraci
exampl timstof provid user abil examin protein
dimens tradit mass spec platform separ ion base weight
howev timstof also separ ion base shape even
weight dimens enabl separ peptid
separ ms platform low abund protein complex protein
mixtur key clinic proteom dr wilson also place import
duti cycl relat percentag ion interest analyz
ion beam timstof pasef technolog enabl platform
duti cycl compar quot single-digit percentag rang orbitrap platform
specif platform uniqu abil concentr ion packet send
detector result timstof requir much smaller sampl
analysi compar platform
dr kenshin ad earli data timstof look promis
mani factor determin success platform specif
believ key understand timstof integr sampl prep
analyt softwar liquid chromatographi platform expert agre
orbitrap reliabl work well step analysi process timstof
util nanoelut hplc orbitrap sync thermo fisher lc
platform expert express prefer either lc strategi dr kenshin
plan review comparison studi decid purchas timstof
cost perspect timstof quot price orbitrap
platform rang
john wilson phd current founder ceo protifi llc present
protifi provid robust reliabl proteom sampl prepar help research
develop determin state health diseas predict drug respons dr
wilson also founder chairman nyc present prior dr
wilson postdoc spring harbor laboratori inc well
consult acm scientif llc dr wilson wide rang field
interest skill includ biochemistri biophys immunolog techniqu elisa ip
etc protein chemistri derivat mass spectrometri analyt
techniqu well engin chemistri languag patent addit
invent commerci antimicrobi devic technolog engin
data protect devic ip theft prevent technolog intend protect engin
evgeni kanshin phd research scientist nyu langon medic center
proteom laboratori present previous research associ
universit de montreal receiv phd chemistri sainte-
justin hospit research center moscow state univers focus mass
spectrometri proteom dr kanshin publish sever time speak
english french russian
estestestestestestestestestestincom statement growth growth growth growth growth growth y/i growth product product product revenu inc servic servic gross gross margin inc growth administr growth stock base sg stock charg ebitda growth acquir intang oper incom ebit growth expens debt incom expens pre-tax pre-tax growth incom tax net net growth dilut basic adj adj net barclay bruker corp
meehan cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
